Bringing Emerging Treatments to All Patients

2025 Presentations

Banner advertising a new treatment option for 2L+ follicular lymphoma, with Genmab and AbbVie logos and a “See details” button.
Darzalex Faspro FDA approval announcement for a new indication based on the AQUILA study